6-Chloro-3-fluoro-2-(trifluoromethyl)pyridine, 95.0%, 5g

(1,1-dioxidotetrahydro-3-thienyl)acetonitrile, 95.0%, 5g

4,4'-Bis(4,6-diphenyl-1,3,5-triazin-2-yl)biphenyl>95.0%(HPLC)(N)1g

GC capillary column ROTI®Cap-5, 50 m, 0.53 mm, 2.00 µm, 1 Piece(s)

4-((1-Cyanocyclobutyl)amino)-2-fluoro-N-methylbenzamide, 95.0%, 25g

4-Bromo-DL-mandelic Acid>98.0%(GC)(T)5g

2-PHENYL-8-AMINOQUINOLINE, 95%, 5g

(5E)-5-(2-isopropoxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 5g

Funnels, 40 mm, 4 mm, 1 Piece

3-Naphthalen-2-yl-3-oxopropionic acid ethyl ester, 5g

2-Bromo-N,N-dimethylbenzenesulfonamide, 98.0%, 5g

6-Ethyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine hydrochloride, 95%, 100mg

1-(2-phenylpropyl)-1H-pyrazol-3-amine, 95.0%, 1g